CGEN
HEALTHCARECompugen Ltd
$2.76+0.04 (+1.47%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CGEN Today?
No stock-specific AI insight has been generated for CGEN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.26$3.24
$2.76
Fundamentals
Market Cap$261M
P/E Ratio7.3
EPS$0.38
Dividend Yield—
Dividend / Share—
ROE0.4%
Profit Margin0.5%
Debt / Equity—
Trading
Volume405K
Avg Volume (10D)—
Shares Outstanding94.6M
CGEN News
20 articles- Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag EstimatesYahoo Finance·May 4, 2026
- Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026Yahoo Finance·May 4, 2026
- Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham ConferenceMarketbeat·Apr 13, 2026
- Compugen to Participate in 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 9, 2026
- Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last YearYahoo Finance·Mar 12, 2026
- Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...Yahoo Finance·Mar 4, 2026
- Compugen Ltd. Q4 2025 Earnings Call SummaryMoby·Mar 2, 2026
- Compugen (CGEN) Beats Q4 Earnings and Revenue EstimatesYahoo Finance·Mar 2, 2026
- Compugen: Q4 Earnings SnapshotYahoo Finance·Mar 2, 2026
- Compugen Reports Fourth Quarter and Full Year 2025 ResultsYahoo Finance·Mar 2, 2026
- Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Feb 26, 2026
- Acadia Pharmaceuticals (ACAD) Q4 Earnings Top EstimatesYahoo Finance·Feb 26, 2026
- Prothena (PRTA) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Feb 19, 2026
- Compugen to Participate in Upcoming Investor ConferencesYahoo Finance·Feb 19, 2026
- Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026Yahoo Finance·Feb 17, 2026
- Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of DirectorsYahoo Finance·Feb 12, 2026
- Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 MillionYahoo Finance·Dec 17, 2025
- Compugen Ltd (CGEN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesYahoo Finance·Nov 12, 2025
- Compugen (CGEN) Reports Q3 Loss, Lags Revenue EstimatesYahoo Finance·Nov 10, 2025
All 20 articles loaded
Price Data
Open$2.68
Previous Close$2.72
Day High$2.84
Day Low$2.68
52 Week High$3.24
52 Week Low$1.26
52-Week Range
$1.26$3.24
$2.76
Fundamentals
Market Cap$261M
P/E Ratio7.3
EPS$0.38
Dividend Yield—
Dividend / Share—
ROE0.4%
Profit Margin0.5%
Debt / Equity—
Trading
Volume405K
Avg Volume (10D)—
Shares Outstanding94.6M
About Compugen Ltd
Compugen Ltd., a clinical-stage therapeutic discovery and development company, is engaged in the research, development, and commercialization of therapeutic candidates and products in Israel, the United States, and Europe. The company is headquartered in Holon, Israel.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—